Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...
Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...
NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...